PDCD1 and neoplasm: Mice that received SCP-treated animal microbiota showed a high response against PD1 therapy with improved anti-tumor immunity, further supporting the hypothesis that the immunomodulatory effects of SCPs are at least partially mediated by changes in the gut microbiota.